MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 140 filers reported holding MERSANA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $102,000 | +78.9% | 15,156 | +6.1% | 0.00% | +100.0% |
| Q1 2022 | $57,000 | 0.0% | 14,280 | +55.7% | 0.00% | 0.0% |
| Q4 2021 | $57,000 | -52.5% | 9,173 | +3.6% | 0.00% | -50.0% |
| Q2 2021 | $120,000 | +166.7% | 8,853 | +218.9% | 0.00% | +100.0% |
| Q1 2021 | $45,000 | -67.6% | 2,776 | -53.3% | 0.00% | -86.7% |
| Q2 2020 | $139,000 | +6850.0% | 5,947 | +485.3% | 0.02% | +1400.0% |
| Q3 2019 | $2,000 | -50.0% | 1,016 | +43.5% | 0.00% | -50.0% |
| Q1 2019 | $4,000 | -66.7% | 708 | +3.7% | 0.00% | -50.0% |
| Q2 2018 | $12,000 | – | 683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |